Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Dabrafenib and Trametinib in Patients With Tumors With BRAFV600E Mutations: Results of the NCI-MATCH Trial Subprotocol HJ. Clin. Oncol 2020 Aug 06;[EPub Ahead of Print], AKS Salama, S Li, ER Macrae, JI Park, EP Mitchell, JA Zwiebel, HX Chen, RJ Gray, LM McShane, LV Rubinstein, D Patton, PM Williams, SR Hamilton, DK Armstrong, BA Conley, CL Arteaga, LN Harris, PJ O'Dwyer, AP Chen, KT Flaherty
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.